Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

TMIGD2 is a leukemic stem cell-specific surface marker in human acute myeloid leukemia

ABSTRACT: TMIGD2 is a leukemic stem cell-specific surface marker in human acute myeloid leukemia

PROVIDER: PRJNA885507 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21762371_1.fastq.gz	Fastqsanger.gz
	SRR21762371_2.fastq.gz	Fastqsanger.gz
	SRR21762372_1.fastq.gz	Fastqsanger.gz
	SRR21762372_2.fastq.gz	Fastqsanger.gz
	SRR21762373_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

TMIGD2 is a leukemic stem cell-specific surface marker in human acute myeloid leukemia

Project description:To comprehensibly understand the genes and pathways associated with TMIGD2 expression in CD34-expressing leukemia cells, RNA-seq was conducted on FACS-purified CD34+TMIGD2+ and CD34+TMIGD2- subfractions of six primary AML specimens.

2023-10-02 | GSE214487 | GEO

Effect of TMIGD2 knockdown on gene expression in HEL cell line

Project description:To investigate the effect of TMIGD2 on transcriptional functions in human AML cell line, we performed gene expression profiling analysis using data obtained from RNA-seq of HEL cells upon TMIGD2 knockdown.

2023-10-02 | GSE214480 | GEO

Pre-leukemic Cebpa mutant myeloid progenitors

Project description:In this study, we use pre-malignant cells from different Cebpa mutant acute myeloid leukemia (AML) models. We have used conditional KO models (CreLoxP) and isolated hematopoietic cells shortly after induction of recombination, in order to look at pre-leukemic cells, which have acquired the first hit, but not yet undergone full malignant transformation. We have sorted granulocyte-macrophage progenitors (GMPs) and the more immature population pre-granulocyte-macrophages (preGMs) from pre-leukemic mice. We analyzed gene-expression profiles in order to find deregulated genes, which make the cells more prone to undergo transformation.

2013-07-08 | E-GEOD-47813 | biostudies-arrayexpress

Pre-leukemic Cebpa mutant myeloid progenitors

2013-07-08 | GSE47813 | GEO

Cysteine-Rich Intestinal Protein 1 is a Novel Surface Marker for Myometrial Stem/Progenitor Cells [SingleCell_RNAseq]

Project description:To find new stem/progenitor myometrium human cell surface marker

2023-06-22 | GSE234527 | GEO

Cysteine-Rich Intestinal Protein 1 is a Novel Surface Marker for Myometrial Stem/Progenitor Cells [SidePopulation_RNAseq]

Project description:To find new stem/progenitor myometrium human cell surface marker

2023-06-22 | GSE234526 | GEO

Cysteine-Rich Intestinal Protein 1 is a Novel Surface Marker for Myometrial Stem/Progenitor Cells [SUSD2_RNAseq]

Project description:To find new stem/progenitor myometrium human cell surface marker

2023-06-22 | GSE234525 | GEO

Ferritinophagy is a Druggable Vulnerability of Quiescent Leukemic Stem Cells in Acute Myeloid Leukemia

Project description:Acute myeloid leukemia (AML) remains a challenging hematological malignancy with poor prognosis and limited treatment options. Post-therapy relapse, particularly driven by leukemic stem cells (LSCs), contributes to therapeutic failure and adverse outcome. Here, we investigated the role of quiescence and its associated molecular mechanisms in AML pathogenesis and identified potential vulnerabilities for therapeutic intervention. We found that quiescent AML cells, enriched for LSC functions, exhibited a distinct gene set that served as a significant prognostic factor for poor outcomes in AML patients. Furthermore, quiescent cells displayed heightened autophagic activity, with a reliance on ferritinophagy, a selective form of autophagy mediated by Nuclear Receptor Coactivator 4 (NCOA4), for iron bioavailability. Inhibition of NCOA4 genetically or chemically showed potent anti-leukemic effects, particularly targeting the LSC compartment. These findings uncover that ferritinophagy inhibition may represent a promising therapeutic strategy for patients with AML.

2024-06-13 | PXD042796 | Pride

RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells to CD19.CD28.4-1BB CAR-T cells in vitro

Project description:We generated a new B7-H3 CAR-T cell costimulatory domain using TMIGD2 and found it was as good or better than the CD28.4-1BB costimulatory domain. Little is known about TMIGD2 signaling, so we examined how each CAR signals individually compared to CD19.CD28.4-1BB control CAR-T cells.

2024-05-08 | GSE254546 | GEO

Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in acute myeloid leukemic patients

Project description:Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in acute myeloid leukemic patients

| PRJNA982842 | ENA